Search

everythinglearnresearchcommunity

for

Search:↓

Cellularity can estimate mesenchymal stem cell concentration in bone marrow, aiding regenerative medicine.

Plucked hair follicles can be used for regenerative therapies and personalized medicine.

Most emerging dermatological treatments lack strong evidence and require more research.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Extracellular vesicles can worsen Alzheimer's but also offer potential for diagnosis and treatment.

SOD1 and KL are promising targets for new hair loss treatments.

Coating surgical meshes with PRP may improve hernia repair outcomes.

A new microneedle treatment could effectively regrow hair in androgenic alopecia.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Hypoxic preconditioning helps human hair follicle stem cells survive oxidative stress.

Treg cells help repair and regenerate tissues by interacting with local cells.

Adipose-derived stem cells can help repair and improve eye tissues and appearance.

The hair growth serum Trichosera® was effective in increasing hair regrowth and density and reducing hair fall without significant side effects.

Human hair follicle stem cells help repair tendon injuries.

Hair follicles can be a good source of stem cells like those from bone marrow.

UC-MSC-derived exosomes may help treat hair loss by promoting hair cell growth through AKT activation.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

ΔNp63α stops TAp73β from working in skin cancer by blocking its access to specific genes, not by directly interacting with it.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

CS12192 effectively treats alopecia areata with better safety than current options.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

SIG-1451 could be a promising new treatment for atopic dermatitis.